Everything listed here is Research Use Only (RUO). Not for human or animal consumption.
Research summaries for peptides, small molecules, and amino acid blends, built from the published literature. Every compound is Research Use Only (RUO) and intended for laboratory research.
Showing 38 compounds
A selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular energy metabolism and NAD+ homeostasis. Preclinical studies have investigated its role in modulating adipose tissue metabolism in diet-induced obesity models.
A pro-apoptotic peptidomimetic that targets the vascular supply of white adipose tissue. Primate studies have investigated selective ablation of adipose vasculature and its effects on adipose tissue metabolism.
A modified fragment (amino acids 177-191) of human growth hormone with a tyrosine substitution. Studies have investigated its lipolytic properties without the growth-promoting or diabetogenic effects associated with full-length hGH.
A long-acting acylated amylin analog designed for once-weekly subcutaneous administration. Studies have investigated its effects on amylin receptor-mediated satiety signaling pathways and metabolic parameters.
A triple-hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. Studies have investigated its multi-receptor pharmacology and effects on metabolic signaling pathways.
An extensively studied GLP-1 receptor agonist with a long half-life enabling once-weekly dosing. Research has investigated its GLP-1 receptor-mediated effects on metabolic signaling pathways and incretin pharmacology.
An extensively studied dual GIP/GLP-1 receptor agonist with a novel mechanism engaging two incretin pathways simultaneously. Research has investigated its dual receptor pharmacology and effects on metabolic signaling.
A synthetic growth hormone-releasing hormone (GHRH) analog conjugated with a Drug Affinity Complex (DAC) that extends its half-life to approximately 6-8 days. Studies have investigated its ability to sustain elevated growth hormone and IGF-1 levels.
A short-acting GHRH analog (Modified GRF 1-29) without the Drug Affinity Complex, producing brief, pulsatile growth hormone release that more closely mimics natural GH secretion patterns.
A synthetic hexapeptide growth hormone secretagogue that acts as a ghrelin receptor (GHS-R1a) agonist. Studies have investigated its potent stimulation of growth hormone release from the anterior pituitary.
A synthetic hexapeptide growth hormone secretagogue with strong GH-releasing activity and notable appetite-stimulating properties. Studies have investigated its role in growth hormone release and gastric motility.
The C-terminal fragment of human growth hormone (amino acids 176-191) studied for its lipolytic properties. Research has investigated its ability to modulate fat metabolism without the growth-promoting or diabetogenic effects of full-length hGH.
A potent synthetic hexapeptide growth hormone secretagogue. Studies have investigated its strong GH-releasing activity and additional cardioprotective properties mediated through CD36 receptor binding.
A long-acting analog of insulin-like growth factor 1 with an arginine substitution at position 3 and a 13-amino acid N-terminal extension. Studies have investigated its enhanced anabolic activity and reduced IGF binding protein affinity.
A selective pentapeptide growth hormone secretagogue that stimulates GH release without significant effects on cortisol, prolactin, or appetite. Studies have investigated its clean GH-releasing profile.
A synthetic analog of the first 29 amino acids of growth hormone-releasing hormone (GHRH 1-29). An extensively studied compound that has been used in diagnostic evaluation of growth hormone secretory capacity.
A stabilized GHRH analog with a trans-3-hexenoic acid modification. An extensively studied compound that has been investigated for its effects on GHRH receptor-mediated signaling and visceral adipose tissue metabolism.
A splice variant of insulin-like growth factor 1 (IGF-1Ec in humans, IGF-1Eb in rodents) produced in response to mechanical loading of muscle tissue. Studies have investigated its role in satellite cell activation and muscle repair mechanisms.
A pentadecapeptide derived from a protective protein found in human gastric juice. Extensive preclinical studies have investigated its effects on angiogenesis, tissue repair mechanisms across multiple organ systems, and gastrointestinal mucosal signaling.
A naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine:copper) found in human plasma. Studies have identified its ability to modulate expression of over 4,000 genes involved in tissue remodeling, tissue repair signaling, and inflammation.
A C-terminal tripeptide fragment of alpha-melanocyte stimulating hormone (alpha-MSH). Studies have investigated its potent anti-inflammatory activity mediated through NF-kappaB pathway suppression.
The sole human cathelicidin-derived antimicrobial peptide. Studies have investigated its broad-spectrum antimicrobial activity, immunomodulatory functions, and role in innate immune defense.
A nine-amino acid neuropeptide hormone produced in the hypothalamus. Studies have investigated its roles in social bonding, stress modulation, tissue repair signaling, and metabolic regulation.
A synthetic peptide representing the active region of thymosin beta-4 (TB4). Studies have investigated its effects on actin regulation, cell migration, angiogenesis, and tissue repair mechanisms across multiple tissue types.
A synthetic hexapeptide analog of angiotensin IV with potent nootropic properties. Preclinical studies have investigated cognitive signaling pathways through hepatocyte growth factor (HGF) pathway activation.
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the natural epithalamin peptide from the pineal gland. Studies have investigated its ability to activate telomerase and its effects on cellular lifespan signaling pathways.
A 24-amino acid mitochondrial-derived peptide (MDP) encoded within the 16S ribosomal RNA region of mitochondrial DNA. Studies have investigated its cytoprotective, neuroprotective, and metabolic regulatory properties.
Nicotinamide adenine dinucleotide, a coenzyme central to cellular energy metabolism and over 500 enzymatic reactions. Studies have investigated its role in sirtuin activation, DNA repair, and age-related metabolic signaling pathways.
A synthetic heptapeptide analog of the immunomodulatory peptide tuftsin with an additional Pro-Gly-Pro sequence. Studies have investigated its anxiolytic, nootropic, and immunomodulatory properties.
A synthetic heptapeptide analog of the ACTH(4-7) fragment with a Pro-Gly-Pro C-terminal extension. Studies have investigated its neuroprotective, nootropic, and neurotrophic properties.
A selective agonist of estrogen-related receptor gamma (ERRgamma), an orphan nuclear receptor involved in oxidative metabolism. Preclinical studies have investigated its potential as an exercise mimetic.
A mitochondria-targeted tetrapeptide that selectively binds to cardiolipin in the inner mitochondrial membrane. Studies have investigated its effects on mitochondrial function in research models of heart failure and mitochondrial myopathy.
A nonapeptide originally isolated from rabbit cerebral venous blood during induced sleep. Studies have investigated its effects on sleep architecture, stress modulation, and neuroendocrine regulation.
A neuropeptide encoded by the KISS1 gene that acts as the master upstream regulator of the reproductive hormone axis. Studies have investigated its role in stimulating GnRH release and modulating reproductive signaling pathways.
A synthetic cyclic heptapeptide analog of alpha-melanocyte stimulating hormone (alpha-MSH). Studies have investigated its activation of melanocortin receptors, producing effects on melanogenesis and melanocortin receptor-mediated signaling pathways.
A regenerative peptide blend combining GHK-Cu (50mg), BPC-157 (10mg), and TB-500 (10mg) totaling 70mg. This formulation combines three compounds studied for their roles in ECM remodeling, angiogenesis, and cell migration.
An enhanced regenerative peptide blend combining GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), and KPV (10mg) totaling 80mg. This formulation adds anti-inflammatory NF-kappaB suppression to the GLOW Stack's tissue-repair mechanisms, designed for research into sensitive or inflamed tissue conditions.
A comprehensive amino acid formulation containing L-Arginine (110mg), L-Citrulline (120mg), L-Glutamine (40mg), L-Taurine (60mg), L-Ornithine (110mg), L-Lysine (70mg), L-Proline (60mg), L-Carnitine (220mg), and NAC (75mg). Studies on individual components have investigated nitric oxide production, mitochondrial energy metabolism, and recovery signaling pathways.
Research Use Only (RUO): The information presented in this library summarizes published scientific research and is provided for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendations. All compounds referenced carry a Research Use Only designation and are intended for laboratory research use only. They are not intended for human or animal consumption. Consult qualified professionals before making any health-related decisions.